मैगज़्टर गोल्ड के साथ असीमित हो जाओ
10,000 से अधिक पत्रिकाओं, समाचार पत्रों और प्रीमियम कहानियों तक असीमित पहुंच प्राप्त करें सिर्फ
कोशिश गोल्ड - मुक्त
Sun Pharma Net Profit Falls on US Antitrust Settlement
Mint Bangalore
|August 01, 2025
Sun Pharmaceutical Industries Ltd.'s revenue from operations for the April-June period beat Street expectations, rising 9.4% year-on-year to ₹13,851 crore. However, the drugmaker's net profit fell due to exceptional items, including settlement costs in a pricing antitrust litigation in the US and the discontinuation of clinical studies on one of its drugs.
The company posted a net profit of ₹2,279 crore in Q1FY26, down 20% from a year earlier.
Healthy double-digit growth in its India business and innovative medicines pipeline boosted its revenue and EBITDA margins during the quarter. The drugmaker has been banking on both segments to drive growth in FY26.
यह कहानी Mint Bangalore के August 01, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Bangalore से और कहानियाँ
Mint Bangalore
Tech focus drives Meesho’s IPO prep
lier this month.
1 mins
November 29, 2025
Mint Bangalore
LIC’s response to voting on RIL, Adani resolutions
A Mint story on Friday reported how Life Insurance Corp. of India Ltd, or LIC, had approved or never opposed resolutions proposed before shareholders of Reliance Industries Ltd (RIL) or any Adani Group company since 1 April 2022, even as it rejected similar proposals at other large companies.
1 min
November 29, 2025
Mint Bangalore
After a year’s pause, AT-I bonds return with Canara Bank
Canara Bank on Friday raised ₹3,500 crore from an additional tier-1 (AT-I) offer, according to three people aware of the matter.
1 min
November 29, 2025
Mint Bangalore
Inside Bengaluru's quiet recycling revolution
Stories from the alleys and gullies of India
4 mins
November 29, 2025
Mint Bangalore
Speciality chemical makers are betting big on pharma
The Street is gravitating toward speciality chemical manufacturers that supply contract development and manufacturing organizations (CDMO) and active pharmaceutical ingredient (API) makers, as uncertainty looms over the chemicals sector.
1 mins
November 29, 2025
Mint Bangalore
The hero who made the movies larger
There are so many Dharmendras to love. Our tribute to the actor whose casual charm belied his larger-than-life aura
4 mins
November 29, 2025
Mint Bangalore
Art Deco feels in Indian fashion
The 100-year-old style has inspired design worldwide. Why doesn't it have a big presence in Indian fashion?
4 mins
November 29, 2025
Mint Bangalore
Indian IT slashes spending on US lobbying on H-1B visa blues
The Indian IT industry has been lowering its lobbying spends in the US in recent years, according to filings made to the US House of Representatives and accessed by Mint.
1 min
November 29, 2025
Mint Bangalore
Fiscal deficit widens on higher capex, lower tax
India’s fiscal deficit for the April-October period rose on higher capital expenditure and lower net tax revenue.
1 min
November 29, 2025
Mint Bangalore
Recreating Dharmendra's timeless style
The late movie superstar was the definition of what it means to have a strong personal style
1 min
November 29, 2025
Listen
Translate
Change font size